Brief: AcelRx Pharmaceuticals Inc Reports Quarterly Loss Per Share Of $1.00
30/03/2023 21:17
March 30 (Reuters) - AcelRx Pharmaceuticals Inc
ACRX.O :
* ACELRX PHARMACEUTICALS REPORTS FULL YEAR AND FOURTH
QUARTER 2022
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* ACELRX PHARMACEUTICALS INC - $20.8 MILLION IN CASH AND
SHORT-TERM INVESTMENTS AS OF DECEMBER 31, 2022
* ACELRX PHARMACEUTICALS INC- QTRLY LOSS PER SHARE $1.00
Source text for Eikon: ID:nPn5bgk9Ma
Further company coverage: ACRX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Talphera
See all newsTalphera Inc reports results for the quarter ended June 30 - Earnings Summary
Talphera Inc expected to post a loss of 7 cents a share - Earnings Preview
Talphera Q1 net loss narrows as costs rise on higher development spending
Talphera Q4 net loss widens as operating expenses rise
Brief: Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial